WebMar 31, 2024 · Klautz RJM, Kappetein AP, Lange R, Dagenais F, Labrousse L, Bapat V, Moront M, Misfeld M, Zeng C, Sabik Iii JF; PERIGON Investigators. Safety, effectiveness and haemodynamic performance of a new stented aortic valve bioprosthesis. Eur J Cardiothorac Surg. 2024 Sep 1;52(3):425-431. doi: 10.1093/ejcts/ezx066. WebThe prosthesis is intact. There is focal tissue overgrowth of the sewing ring. The leaflets move freely and open and close completely. No thrombi or vegetations are present. Also present in the same container are multiple detached fragments of tan soft tissue measuring in aggregate 3.0×2.5cm. The specimen is photographed.
Comparison between three types of stented pericardial aortic …
WebSep 1, 2024 · The Carpentier-Edwards Perimount Magna Ease (Edwards Lifesciences) pericardial bioprosthesis has demonstrated satisfying hemodynamics at midterm follow-up, but its durability remains unclear. We report our 10-year experience with this third-generation valve implanted in the aortic position, with particular attention to structural valve ... WebJun 29, 2024 · The aim of this study was to compare the outcome after TAVR with the Sapien 3 and SAVR with the Perimount Magna Ease bovine pericardial prostheses. ... 689 underwent TAVR with Sapien 3 bioprosthesis and 1311 patients underwent SAVR with Perimount Magna Ease prosthesis. The mean follow-up of the overall series and of the … disaster recovery plan docx
Technical Details of Aortic Valve Replacement using …
WebMay 1, 2016 · The Magna Ease valves demonstrated excellent durability and hydrodynamic performance after an equivalent of 25 years of simulated in vitro wear. All study valves successfully endured 1 billion cycles of simulated wear, 5 times longer than the standard requirement for a tissue valve as stipulated in ISO 5840. Section snippets Valve Selection WebMay 29, 2024 · Methods: From 2007 to 2016 at our center, 338 patients underwent aortic valve replacement using the Perimount Magna Ease pericardial bioprosthesis. Patients were prospectively followed (mean 6.6 ± 2.6 years) with clinical evaluation and yearly echocardiography. Follow-up was 98% complete (7 patients lost) for a total of 2238 valve … WebJul 28, 2010 · This is a prospective, single-arm, multi-center, interventional study to be conducted in the US and outside the US (OUS). This study will enroll a minimum of 225 patients implanted with the study valve in order to achieve 101 aortic valve replacement subjects each followed for a minimum of 8 years. founders ib